But at this point, that level of industry is not where I, as an admitted defender of the pharma / bio industry, am willing to stick my neck out. I've followed a good number of companies over the last 20 years, and many have been able to research and develop without resorting to such a "strategy."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.